110534 ⎘
ssDNA viruses; Details; Parvoviridae Dependovirus, e.g. adenoassociated viruses
Sub-classes:RIBOZYME-ACTIVATED RNA CONSTRUCTS AND USES THEREOF
#2HIGH-EFFICIENCY RECONSTITUTION OF RNA MOLECULES
#3HIGH THROUGHPUT ENGINEERING OF FUNCTIONAL AAV CAPSIDS
#4VIRAL PARTICLE DETECTION METHOD, INFORMATION PROCESSING DEVICE, AND VIRAL PARTICLE DETECTION PROGRAM
#5ENGINEERING AAV
#6VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES
#7RECOMBINANT AAV VECTORS EXPRESSING OSTEOPROTECTIVE GENES, INCLUDING HAS2 AND LUBRICIN, USEFUL IN THE TREATMENT OF OSTEOARTHRITIS AND RELATED JOINT CONDITIONS IN MAMMALS
#8HIGH THROUGHPUT ENGINEERING OF FUNCTIONAL AAV CAPSIDS
#9METHODS OF OPTIMISING EXPRESSION AND DELIVERY OF MITOCHONDRIAL PROTEINS
#10Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells via viral delivery
#11Method for preventing or treating metabolic disorder
#12HIGH-EFFICIENCY RECONSTITUTION OF RNA MOLECULES
#13Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells via viral delivery
#14DNA IMPURITIES IN A COMPOSITION COMPRISING A PARVOVIRAL VIRION
#15Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells using microcarriers
#16Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells via viral delivery
#17Vaccines based on mutant CALR and JAK2 and their uses
#18Gene editing method using virus
#19COMPOSITIONS AND METHODS FOR TREATING DISEASES
#20ADENO-ASSOCIATED VIRUS (AAV)VECTORS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER OCULAR DISEASES AND DISORDERS
#21Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy
#22Engineering AAV
#23Recombinant AAV vectors expressing osteoprotective genes, including HAS2 and lubricin, useful in the treatment of osteoarthritis and related joint conditions in mammals
#24Mutant viral capsid libraries and related systems and methods
#25SCALABLE METHOD FOR PRODUCING TRANSFECTION REAGENTS
#26SCALABLE MANUFACTURING PLATFORM FOR VIRAL VECTOR PURIFICATION AND VIRAL VECTORS SO PURIFIED FOR USE IN GENE THERAPY
#27Chimeric adeno-associated virus/ bocavirus parvovirus vector
#28DNA impurities in a composition comprising a parvoviral virion
#29Compositions and methods for treating diseases
#30Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy
#31Proviral plasmids and production of recombinant adeno-associated virus
#32COMPOSITIONS AND METHODS TO PREVENT AAV VECTOR AGGREGATION
#33Chimeric adeno-associated virus/ bocavirus parvovirus vector
#34Proviral plasmids and production of recombinant adeno-associated virus
#35Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy
#36USE OF APOPTOSIS INHIBITING COMPOUNDS IN DEGENERATIVE NEUROLOGICAL DISORDERS
#37Compositions and methods to prevent AAV vector aggregation
#38Truncated CMV promoters and vectors containing same
#39Use of apotosis inhibiting compounds in degenerative neurological disorders
#40Compositions and methods for treating female fertility
#41Compositions and methods to prevent AAV vector aggregation
#42Compositions and methods for treating female fertility